| Metric | Q2 2027 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Revenue | 26.0B +12.5% | 23.1B +12.1% | 20.6B -1.1% | 20.8B -13.1% | 24.0B |
| Cost of Revenue | 17.4B +11.9% | 15.5B +11.7% | 13.9B +1.5% | 13.7B -13.6% | 15.9B |
| Gross Profit | 8.6B +13.7% | 7.5B +12.9% | 6.7B -6.1% | 7.1B -12.2% | 8.1B |
| Operating Expenses | 5.0B +0.8% | 5.0B +0.3% | 5.0B +7.3% | 4.6B +0.1% | 4.6B |
| R&D | 0 | 0 | 0 | 0 | 0 |
| SG&A | 4.5B +0.7% | 4.4B +0.3% | 4.4B +6.0% | 4.2B -0.4% | 4.2B |
| Operating Income | 3.5B +39.0% | 2.6B +49.5% | 1.7B -31.2% | 2.5B -28.5% | 3.5B |
| EBITDA | 4.2B +31.2% | 3.2B +36.4% | 2.3B -22.2% | 3.0B -24.3% | 4.0B |
| Net Income | 2.4B +47.4% | 1.6B +62.8% | 1.0B -38.1% | 1.6B -32.6% | 2.4B |
| EPS (Basic) | $4.28 +47.6% | $2.90 +61.1% | $1.80 -37.5% | $2.88 -32.7% | $4.28 |
| EPS (Diluted) | $4.27 +47.2% | $2.90 +60.2% | $1.81 -37.2% | $2.88 -32.6% | $4.27 |
| Shares (Diluted) | 560.0M +0.0% | 560.0M +0.0% | 560.0M +0.0% | 560.0M +0.0% | 560.0M |